“We have set out to release a serialized sequence of contributions “in which we discuss next-wave biologics (proteins, cell therapies) and associated platform technologies including diagnostics that collectively appear poised to upend our entire approach to the management of cancer.  Each subsequent contribution will be informed both by our understanding of emerging technologies and firsthand discussions with many of the leading innovator companies developing them.  Companies of the likes of Tidal/SanofiAletaObsidianAbintusSpotlightStrand, and Xyphos/Astellas.  We’ve spoken with them all, and while each offers a unique vision of the future, common themes are beginning to emerge.”

Read the full whitepaper

To read the full whitepaper, please complete the form below.

Sign me up to receive regular insights from Lumanity
This field is for validation purposes and should be left unchanged.